Skip to main content
Clinical Trials/IRCT20210415050983N2
IRCT20210415050983N2
Recruiting
Phase 2

A Comparison of the effect of dexmedetomidine and remifentanil on analgesia and respiratory parameters in patients undergoing stereotactic brain biopsy

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Stereotactic biopsy.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18\-50 years old candidate for stereotactic
  • Patients with supratentorial lesions with or without hydrocephalus
  • No dysfunction of the liver and kidneys
  • No drug addiction
  • Consent to participate in the study

Exclusion Criteria

  • BMI \>35 or\<16
  • mental disorder
  • Uncontrolled epilepsy
  • Alcohol and drug abuse
  • Having a comorbid condition such as high blood pressure
  • History of chronic pain
  • Patients with brainstem lesions
  • Intubated patients

Outcomes

Primary Outcomes

Not specified

Similar Trials